InsidersTradesSigma
에임드바이오 Stock: price and directors' dealings · South Korea · DART (FSS)
Track the 에임드바이오 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 에임드바이오 has logged 16 insider filings. The latest transaction was reported on 5 February 2026 (Other). Among the most active insiders: 인터베스트. The full history is openly available.
16
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
·
0 ops.
Sell Volume
2Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 5 February 2026
Declarations16 total
10,590,823 sharesKRXDART:20251208000072
Ideal exit: 31 Aug 2026 (T+270)
16 of 16 declarations